JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Sex and Gender Omic biomarkers in men and women with COPD: Considerations for precision medicine.

Chest 2021 March 19
Sex and gender differences in lung health and disease are imperative to consider and study if precision pulmonary medicine is to be achieved. The development of reliable COPD biomarkers has been elusive and the translation of biomarkers to clinical care has been limited. Useful and effective biomarkers must be developed with attention to clinical heterogeneity of COPD-there is inherent heterogeneity related to grouping women and men together in the studies of COPD. Considering sex and gender differences and influences related to Omics may represent progress in susceptibility, diagnostic, prognostic and therapeutic biomarker development and clinical innovation to improve the lung health of men and women.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app